Edit Content
Bizwit-Logo-Final

Bizwit Research & Consulting LLP is a global provider of business intelligence & consulting services. We have a strong primary base of key industry leaders along with the chain of industry analysts to analyze the market trends and its future impact in order to estimates and forecast different business segments and markets. 

Global Blood Plasma Derivatives Market to reach USD 89563.6 million by the end of 2030.

Global Blood Plasma Derivatives Market Size study & Forecast, by Type (Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Others), by Application (Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand'S Disease, Other Application), by End User (Hospitals, Clinics, Others) and Regional Analysis, 2023-2030

Product Code: HLSB-60011209
Publish Date: 13-07-2023
Page: 200

Global Blood Plasma Derivatives Market is valued at approximately USD 43650.9 million in 2022 and is anticipated to grow with a healthy growth rate of more than 9.4% over the forecast period 2023-2030. The blood plasma derivatives market refers to the segment of the pharmaceutical industry that involves the collection, processing, and commercialization of therapeutic products derived from human blood plasma. These derivatives are obtained through a complex manufacturing process that includes fractionation, purification, and sterilization to isolate and extract specific proteins, antibodies, and other bioactive substances found in blood plasma. These products are used for various therapeutic purposes, including treating immune disorders, coagulation disorders, and certain genetic diseases. The blood plasma derivatives market is being driven by factors such as the increasing geriatric population that are more susceptible to developing infectious diseases and the Increasing prevalence of chronic diseases.

Blood plasma derivatives play a crucial role in the treatment of various medical conditions and provide therapeutic options for patients with immune deficiencies, coagulation disorders, and other diseases. According to the International Diabetes Federation (IDF), diabetes can afflict 537 million adults globally in 2021, with one in ten experiencing other diabetes. Furthermore, geriatric, and obese populations are predisposed to chronic diseases. According to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050.Thus, the growing prevalence of chronic disease and the growing aging population fueling the growth of the market. In addition, increasing awareness & diagnosis of rare diseases and technological advancements in plasma fractionation. However, strict regulatory compliances may hinder the growth of the market throughout the forecast period of 2023-2030.

The key regions considered for the Global Blood Plasma Derivatives Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in 2022 owing to the well-developed healthcare infrastructure, including hospitals, clinics, and diagnostic centers. These facilities have advanced capabilities for blood plasma collection, processing, and manufacturing of derivatives, leading to a robust market for plasma-based products. North America is also considered the fastest growing region during the forecasted period due to the high demand for plasma-derived products and reimbursement systems.

Major market player included in this report are:
Baxter International Inc.
Bayer AG
CSL Limited
Fusion Health Care Pvt. Ltd.
Grifols S.A.
Kedrion S.p.A.
LFB S.A.
Octapharma AG
Sanofi S.A.
Takeda Pharmaceutical Company Limited
Recent Developments in the Market:
• In March 2020, Grifols collaborates with the United States Biomedical Advanced Research Development Authority (BARDA), the Food and Drug Administration (FDA) and other Federal public health agencies to collect plasma from convalescent COVID-19 patients, process this specific plasma into a hyperimmune globulin and support the necessary preclinical and clinical studies to determine if anti-SARS-CoV-2 hyperimmune globulin therapy can successfully be used to treat COVID-19 disease. Grifols will volunteer its expertise and resources in the areas of plasma collection using its network of FDA-approved plasma donor centers; test and qualify donors in conjunction with other health agencies; process plasma into hyperimmune globulin in its purpose-built facility in Clayton, North Carolina, for the isolated processing of immune globulins to treat emerging infectious diseases.

Global Blood Plasma Derivatives Market Report Scope:
ü Historical Data – 2020 – 2021
ü Base Year for Estimation – 2022
ü Forecast period – 2023-2030
ü Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
ü Segments Covered -, Type, Application, End User, Region
ü Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa
ü Customization Scope – Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:
Albumin
Factor VIII
Factor IX
Immunoglobulin
Hyperimmune Globulin
Others

By Application:
Hemophilia
Hypogammaglobulinemia
Immunodeficiency Diseases
Von Willebrand’S Disease
Other Application

By End User:
Hospitals
Clinics
Others End User

By Region:

North America
U.S.
Canada

Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC

Latin America
Brazil
Mexico

Middle East & Africa
Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Million)
1.2.1. Blood Plasma Derivatives Market, by Region, 2020-2030 (USD Million)
1.2.2. Blood Plasma Derivatives Market, by Type, 2020-2030 (USD Million)
1.2.3. Blood Plasma Derivatives Market, by Application, 2020-2030 (USD Million)
1.2.4. Blood Plasma Derivatives Market, by End User, 2020-2030 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Blood Plasma Derivatives Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Industry Evolution
2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Blood Plasma Derivatives Market Dynamics
3.1. Blood Plasma DerivativesMarket Impact Analysis (2020-2030)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of chronic diseases
3.1.1.2. Growing Geriatric Population
3.1.2. Market Challenges
3.1.2.1. Strict regulatory compliances
3.1.3. Market Opportunities
3.1.3.1. Increasing awareness & diagnosis of rare diseases
3.1.3.2. Technological advancements in plasma fractionation
Chapter 4. Global Blood Plasma DerivativesMarket Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Porter’s 5 Force Impact Analysis
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.3.5. Environmental
4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion
Chapter 5. Global Blood Plasma DerivativesMarket, by Type
5.1. Market Snapshot
5.2. Global Blood Plasma DerivativesMarket by Type, Performance – Potential Analysis
5.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by Type 2020-2030 (USD Million)
5.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
5.4.1. Albumin
5.4.2. Factor VIII
5.4.3. Factor IX
5.4.4. Immunoglobulin
5.4.5. Hyperimmune Globulin
5.4.6. Others
Chapter 6. Global Blood Plasma DerivativesMarket, by Application
6.1. Market Snapshot
6.2. Global Blood Plasma DerivativesMarket by Application, Performance – Potential Analysis
6.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by Application 2020-2030 (USD Million)
6.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
6.4.1. Hemophilia
6.4.2. Hypogammaglobulinemia
6.4.3. Immunodeficiency Diseases
6.4.4. Von Willebrand’S Disease
6.4.5. Other Application
Chapter 7. Global Blood Plasma DerivativesMarket, by End User
7.1. Market Snapshot
7.2. Global Blood Plasma DerivativesMarket by End User, Performance – Potential Analysis
7.3. Global Blood Plasma DerivativesMarket Estimates & Forecasts by End User 2020-2030 (USD Million)
7.4. Blood Plasma DerivativesMarket, Sub Segment Analysis
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Others End User
Chapter 8. Global Blood Plasma DerivativesMarket, Regional Analysis
8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Blood Plasma DerivativesMarket, Regional Market Snapshot
8.4. North America Blood Plasma DerivativesMarket
8.4.1. U.S. Blood Plasma DerivativesMarket
8.4.1.1. Type breakdown estimates & forecasts, 2020-2030
8.4.1.2. Application breakdown estimates & forecasts, 2020-2030
8.4.1.3. End User breakdown estimates & forecasts, 2020-2030
8.4.2. Canada Blood Plasma DerivativesMarket
8.5. Europe Blood Plasma DerivativesMarket Snapshot
8.5.1. U.K. Blood Plasma DerivativesMarket
8.5.2. Germany Blood Plasma DerivativesMarket
8.5.3. France Blood Plasma DerivativesMarket
8.5.4. Spain Blood Plasma DerivativesMarket
8.5.5. Italy Blood Plasma DerivativesMarket
8.5.6. Rest of Europe Blood Plasma DerivativesMarket
8.6. Asia-Pacific Blood Plasma DerivativesMarket Snapshot
8.6.1. China Blood Plasma DerivativesMarket
8.6.2. India Blood Plasma DerivativesMarket
8.6.3. Japan Blood Plasma DerivativesMarket
8.6.4. Australia Blood Plasma DerivativesMarket
8.6.5. South Korea Blood Plasma DerivativesMarket
8.6.6. Rest of Asia Pacific Blood Plasma DerivativesMarket
8.7. Latin America Blood Plasma DerivativesMarket Snapshot
8.7.1. Brazil Blood Plasma DerivativesMarket
8.7.2. Mexico Blood Plasma DerivativesMarket
8.8. Middle East & Africa Blood Plasma DerivativesMarket
8.8.1. Saudi Arabia Blood Plasma DerivativesMarket
8.8.2. South Africa Blood Plasma DerivativesMarket
8.8.3. Rest of Middle East & Africa Blood Plasma DerivativesMarket

Chapter 9. Competitive Intelligence
9.1. Key Company SWOT Analysis
9.1.1. Company 1
9.1.2. Company 2
9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Baxter International Inc.
9.3.1.1. Key Information
9.3.1.2. Overview
9.3.1.3. Financial (Subject to Data Availability)
9.3.1.4. Product Summary
9.3.1.5. Recent Developments
9.3.2. Bayer AG
9.3.3. CSL Limited
9.3.4. Fusion Health Care Pvt. Ltd.
9.3.5. Grifols S.A.
9.3.6. Kedrion S.p.A.
9.3.7. LFB S.A.
9.3.8. Octapharma AG
9.3.9. Sanofi S.A.
9.3.10. Takeda Pharmaceutical Company Limited
Chapter 10. Research Process
10.1. Research Process
10.1.1. Data Mining
10.1.2. Analysis
10.1.3. Market Estimation
10.1.4. Validation
10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

At Bizwit Research and Consultancy, we employ a thorough and iterative research methodology with the goal of minimizing discrepancies, ensuring the provision of highly accurate estimates and predictions over the forecast period. Our approach involves a combination of bottom-up and top-down strategies to effectively segment and estimate quantitative aspects of the market, utilizing our proprietary data & AI tools. Our Proprietary Tools allow us for the creation of customized models specific to the research objectives. This enables us to develop tailored statistical models and forecasting algorithms to estimate market trends, future growth, or consumer behavior. The customization enhances the accuracy and relevance of the research findings.
We are dedicated to clearly communicating the purpose and objectives of each research project in the final deliverables. Our process begins by identifying the specific problem or challenge our client wishes to address, and from there, we establish precise research questions that need to be answered. To gain a comprehensive understanding of the subject matter and identify the most relevant trends and best practices, we conduct an extensive review of existing literature, industry reports, case studies, and pertinent academic research.
Critical elements of methodology employed for all our studies include:
Data Collection:
To determine the appropriate methods of data collection based on the research objectives, we consider both primary and secondary sources. Primary data collection involves gathering information directly from various industry experts in core and related fields, original equipment manufacturers (OEMs), vendors, suppliers, technology developers, alliances, and organizations. These sources encompass all segments of the value chain within the specific industry. Through in-depth interviews, we engage with key industry participants, subject-matter experts, C-level executives of major market players, industry consultants, and other relevant experts. This allows us to obtain and validate critical qualitative and quantitative information while evaluating market prospects. AI and Big Data are instrumental in our primary research, providing us with powerful tools to collect, analyze, and derive insights from data efficiently. These technologies contribute to the advancement of research methodologies, enabling us to make data-driven decisions and uncover valuable findings.
In addition to primary sources, we extensively utilize secondary sources to enhance our research. These include directories, databases, journals focusing on related industries, company newsletters, and information portals such as Bloomberg, D&B Hoovers, and Factiva. These secondary sources enable us to identify and gather valuable information for our comprehensive, technical, market-oriented, and commercial study of the market. Additionally, we utilize AI algorithms to automate the collection of vast amounts of data from various sources such as surveys, social media platforms, online transactions, and web scraping. And employ Big Data technologies for storage and processing of large datasets, ensuring that no valuable information is missed during the data collection process.
Data Analysis:
Our team of experts carefully examine the gathered data using suitable statistical techniques and qualitative analysis methods. For quantitative analysis, we employ descriptive statistics, regression analysis, and other advanced statistical methods, depending on the characteristics of the data. This analysis may also incorporate the utilization of AI tools and big data analysis techniques to extract meaningful insights.
To ensure the accuracy and reliability of our findings, we extensively leverage data science techniques, which help us minimize discrepancies and uncertainties in our analysis. We employ Data Science to clean and preprocess the data, ensuring its quality and reliability. This involves handling missing data, removing outliers, standardizing variables, and transforming data into suitable formats for analysis. The application of data science techniques enhances our accuracy, efficiency, and depth of analysis, enabling us to stay competitive in dynamic market environments.
Market Size Estimation:
Our proprietary data tools play a crucial role in deriving our market estimates and forecasts. Each study involves the creation of a unique and customized model. The model incorporates the gathered information on market dynamics, technology landscape, application development, and pricing trends. AI techniques, such as machine learning and deep learning, aid us to analyze patterns within the data to identify correlations, trends, and relationships. By recognizing patterns in consumer behavior, purchasing habits, or market dynamics, our AI algorithms aid us in more precise estimations of market size. These factors are simultaneously analyzed within the model, allowing for a comprehensive assessment. To quantify their impact over the forecast period, correlation, regression, and time series analysis are employed.
To estimate and validate the market size, we employ both top-down and bottom-up approaches. The preference is given to a bottom-up approach, where key regional markets are analyzed as separate entities. This data is then integrated to obtain global estimates. This approach is crucial as it provides a deep understanding of the industry and helps minimize errors.
In our forecasting process, we consider various parameters such as economic tools, technological analysis, industry experience, and domain expertise. By taking all these factors into account, we strive to produce accurate and reliable market forecasts. When forecasting, we take into consideration several parameters, which include:
Market driving trends and favorable economic conditions
Restraints and challenges that are expected to be encountered during the forecast period.
Anticipated opportunities for growth and development
Technological advancements and projected developments in the market
Consumer spending trends and dynamics
Shifts in consumer preferences and behaviors.
The current state of raw materials and trends in supply versus pricing
Regulatory landscape and expected changes or developments.
The existing capacity in the market and any expected additions or expansions up to the end of the forecast period.
To assess the market impact of these parameters, we assign weights to each one and utilize weighted average analysis. This process allows us to quantify their influence on the market and derive an expected growth rate for the forecasted period. By considering these various factors and applying a weighted analysis approach, we strive to provide accurate and reliable market forecasts.
Insight Generation & Report Presentation:
After conducting the research, our experts analyze the findings in relation to the research objectives and the specific needs of the client. They generate valuable insights and recommendations that directly address the client’s business challenges. These insights are carefully connected to the research findings to provide a comprehensive understanding.
Next, we create a well-structured research report that effectively communicates the research findings, insights, and recommendations to the client. To enhance clarity and comprehension, we utilize visual aids such as charts, graphs, and tables. These visual elements are employed to present the data in an engaging and easily understandable format, ensuring that the information is accessible and visually appealing to the client. Our aim is to deliver a clear and concise report that conveys the research findings effectively and provides actionable recommendations to meet the client’s specific needs.

Need Assistance

Contact Person -
Krishant Mennon
Call us @
+ 91 99931 15879
Email: sales@bizwitresearch.com

Checkout

Why Choose Us?

Quality over Quantity

Backed by 60+ paid data sources our reports deliver crisp insights with no compromise quality.

Analyst Support

24x7 Chat Support plus
free analyst hours with every purchase

Flawless Methodology

Our 360-degree approach of market study, our research methods leave stones unturned.

Enquiry Now